Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF
✍ Scribed by Andrew Baird; Pierre Mormède; Peter Böhlen
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 404 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Using a radioimmunoassay for bovine pituitary fibroblast growth factor (FGF), we have established the presence of the immunoreactive mitogen in extracts of a transplantable mouse chondrosarcoma. Both neutral and acidic extracts of the tumor contain an immunoreactive FGF (ir-FGF) that cross-rearts in a parallel and dose-dependent fashion in the radioimmunoassay . The ir-FGF is retained on heparin-Sepharose affinity columns and can be detected in the same molecular weight forms as rat pituitary FGF. Mice (C57/B1) inoculated with the tumor (10 mg, im) show a decreased rate of tumor growth when passively immunized with the antiserum to FGF. The results establish the presence of FGF in this tumor and implicate its role in the etiology of its development.
📜 SIMILAR VOLUMES
## Background: Defects of articular cartilage are an unsolved problem in orthopaedics. in the present study, we tested the hypothesis that gene transfer of human fibroblast growth factor 2 (fgf-2) via transplantation of encapsulated genetically modified articular chondrocytes stimulates chondrogene